• 대한조현병학회지
• /
• 제22권2호
• /
• pp.21-33
• /
• 2019

Objectives: The current study covers a secondary revision of the guidelines for the pharmacotherapy of schizophrenia issued by the Korean Medication Algorithm for Schizophrenia (KMAP-SCZ) 2001, specifically for co-existing symptoms and antipsychotics-related side-effects in schizophrenia patients. Methods: An expert consensus regarding the strategies of pharmacotherapy for positive symptoms of schizophrenia, co-existing symptoms of schizophrenia, and side-effect of antipsychotics in patients with schizophrenia was retrieved by responses obtained using a 30-item questionnaire. Results: For the co-existing symptoms, agitation could be treated with oral or intramuscular injection of benzodiazepine or antipsychotics; depressive symptoms with atypical antipsychotics and adjunctive use of antidepressant; obsessive-compulsive symptoms with selective serotonin reuptake inhibitors and antipsychotics other than clozapine and olanzapine; negative symptoms with atypical antipsychotics or antidepressants; higher risk of suicide with clozapine; comorbid substance abuse with use of naltrexone or bupropion/varenicline, respectively. For the antipsychotics-related side effects, anticholinergics (extrapyramidal symptom), propranolol and benzodiazepine (akathisia), topiramate or metformin (weight gain), change of antipsychotics to aripiprazole (hyperprolactinemia and prolonged QTc) or clozapine (tardive dyskinesia) could be used. Conclusion: Updated pharmacotherapy strategies for co-existing symptoms and antipsychotics-related side effects in schizophrenia patients as presented in KMAP-SCZ 2019 could help effective clinical decision making of psychiatrists as a preferable option.

• Clinical and Experimental Pediatrics
• /
• 제45권3호
• /
• pp.376-382
• /
• 2002

목 적 : 최근에 고전적인 진단 기준을 만족하지 않는 비정형 가와사키병에 대한 보고가 증가하고 있어 이의 조기 진단 및 치료를 위한 진단 기준을 마련하고자 하였다. 방 법: 1998년 1월부터 2000년 6월까지 가와사키 병으로 진단 받은 환아 총 167명을 대상으로 비정형 가와사키병의 임상적 특징을 전형적 가와사키병과 비교 분석하였다. 결 과 : 1) 총 환아 167명 중 비정형 가와사키병은 28명(16.8%)이었고, 1세 미만 환아의 비율은 25.0%로 전형적 가와사키병에서의 16.5% 보다 높은 경향을 보였다(P=NS). 2) 전형군과 비정형군 간에 임상 증상의 발생 빈도를 비교하면 구강 점막 변화를 제외하고 안구 결막의 충혈, 부정형 발진, 사지 말단의 변화, 경부 림프절 종대는 비정형군에서 유의하게 낮았다. 비정형군의 임상 증상 중에서 구강 점막 변화가 제일 흔하며(96.4%), 다음으로 안구 결막 충혈(57.1%), 부정형 발진(46.4%)의 순이었다. 급성기의 검사 소견은 대부분 두 군간에 차이가 없었으며, 적혈구 용적 <35%, ESR >30mm/hr, CRP >3.1 mg/dL의 빈도는 두 군에서 모두 높았다. 3) 관상동맥 병변은 비정형군에서는 28명 중 7명(25.0%), 전형군에서는 139명 중 20명(14.4%)에서 발생하여 비정형군에서 빈도가 더 높은 경향을 보였다(P=NS). 4) 관상동맥 병변이 있는 환아 총 27명 중에서 7명(25.9%)이 비정형 가와사키병 환아였다. 5) 구강 점막 변화를 주기준, 안구 결막 충혈, 부정형 발진 및 적혈구 용적 <35%, ESR >30 mm/hr 또는 CRP >3.1 mg/dL을 부기준으로 할 때 발열과 주 기준 그리고 2개 이상의 부기준이 있을 때, 또는 발열과 4개의 부기준이 있을 때를 비정형 가와사키병의 진단 기준으로 정할 때 민감도는 89.3%였다. 결 론 : 비정형 가와사키병의 조기 진단을 위해 본 연구에서 제안한 진단 기준이 도움이 되리라고 생각된다.

• 한국직업건강간호학회지
• /
• 제28권4호
• /
• pp.242-252
• /
• 2019

Purpose: This study aimed to identify factors influencing depressive symptoms in public and private sector employees. Methods: Survey data on 23,602 workers who had worked in the public or private sector were obtained from the 2014 Korean Working Condition Survey (KWCS). Symptoms of depression were measured using the WHO-5 Well-being Index. Data were analyzed using a $x^2$ test, t-test, and multivariate stepwise logistic regression to determine the factors affecting the symptoms of depression. Results: First, the prevalence of depressive symptoms was 41.1 % in public sector employees and 43.4 % in private sector employees. Second, the factors commonly affecting depressive symptoms in public and private sector employees were residence area, cognitive demands, development opportunities, social support from colleagues, social support from supervisors, social community at work, job rewards, and work-family conflict. In addition, age, company size, atypical work, ergonomic risks, quantitative demands, emotional demands, influence, and job insecurity were found to be predictors of depressive symptoms unique to private sector employees. Conclusion: Mental health programs including the employee assistance program (EAP) should be developed and implemented after considering the risk factors affecting depressive symptoms.

• 생물정신의학
• /
• 제14권1호
• /
• pp.68-71
• /
• 2007

Quetiapine is an atypical antipsychotic drug with a benign side effect profile. However, recent studies have reported that thyroid dysfunction is associated with quetiapine treatment. The authors report a patient with DSM-IV bipolar I disorder who developed subclinical hypothyroidism during quetiapine treatment. The patient showed no significant clinical symptoms, but only abnormal thyroid function test findings including antithyroglobulin antibody. The abnormal thyroid function test findings were normalized after discontinuation of quetiapine. The subclinical hypothyroidism developed during quetiapine treatment may be associated with autoimmune process.

• Clinical and Experimental Pediatrics
• /
• 제52권3호
• /
• pp.389-391
• /
• 2009

AHS는 항경련제에 의한 부작용으로 드물게 발생하지만 생명을 위협할 수 있는 지연형 면역반응이다. 보통 항경련제 복용 후 1-8주 사이에 고열, 피부발진, 림프절병증의 임상 증세를 나타내고, 혈액, 간, 신장, 또는 폐 등의 내부 장기를 침범한다. AHS는 항경련제에 의한 부작용으로 증상이 전신적으로 다양하게 나타날 수 있다. 그리고 전염성 단핵구증이나 가와사키병과 같은 전신적 질환들과도 유사한 임상증상들을 보이기 때문에 이런 질환들과 감별하는 것이 중요하고 사망률도 10%에서 보고되고 있어 조기에 발견하고 치료하는 것이 중요하다. 저자들은 임상증상과 초기 검사가 전염성 단핵구증과 비전형적 가와사키병과 매우 유사한 lamotigine에 의한 AHS 1예를 보고하는 바이다.

• 생물정신의학
• /
• 제2권1호
• /
• pp.140-143
• /
• 1995

Tardive dyskinesia(TD), typically appearing as an undesirable side effect of a long term antipsychotic drug treatment has gained increased attention in recent times due to the discovery of many TD variants. This is a single case study of a patient who has undergone more than 8 years of high dosage antipsychotic treatment. After altering the type and dosage of antipsychotic medication 3 months prior to visit, the patient showed relatively abrupt onset symptoms of severe tremor and dystonia. These symptoms, appearing in clear consciousess, got better to a certain degree after 48 hours, worsened for 12 hours, and then improved again. Subsequently there was no continuing movement disorder. Several tests and consultation were carried out. However except for the medication factor, no other possible causes for such disabling symptoms were found. This clinical condition was thought to be akin to tardive tremor, a variant of TD. Furthermore, the course was atypical.

• Journal of Yeungnam Medical Science
• /
• 제33권1호
• /
• pp.1-7
• /
• 2016

The two distinctive clinical features of varicella-zoster virus (VZV) are varicella (chickenpox) by primary infection and zoster (singles) by the reactivation of latent infection. In addition to the two typical clinical symptoms mentioned above, diverse clinical manifestations have been reported as a result of VZV reactivation, including chronic radicular pain without rash, visual loss, facial palsy, dysphagia, sore throat, odynophagia, otalgia, hearing loss, dizziness, headache, hemiplegia, etc. Most of these symptoms are derived from neuropathy and vasculopathy of affected nerves and arteries. Diagnosis of VZV disease can be difficult if there is no appearance of a skin rash during development of atypical symptoms. In addition to natural infection, vaccination and anti-viral agent treatment have influenced the changes of epidemics and clinical presentations of varicella and zoster. In this article, diverse clinical manifestations caused by VZV reactivation, particular without skin rash, are reviewed.

• Journal of Korean Neurosurgical Society
• /
• 제56권3호
• /
• pp.269-271
• /
• 2014

Spinal subdural hematoma is a rarely reported disease and spontaneous spinal subdural hematomas (SSDH) without underlying pathological changes are even rarer. The patients usually show typical symtoms such as back pain, quadriplegia, paraplegia or sensory change. But rarely, patients may show atypical symptoms such as hemiparesis and misdiagnosed to cerebrovascular accident. We recently experienced a case of SSDH, where the patient initially showed vague symptoms, such as the sudden onset of headache which we initially misdiagnosed as subarachnoid hemorrhage. In this case, the headache of patient improved but the neck pain persisted until hospital day 5. Therefre, we conducted the MRI of cervical spine and finally confirmed SSDH. The patient was managed conservatively and improved without recurrence. In this case report, we discuss the clinical features of SSDH with emphasis on the importance of an early diagnosis.

• 한국임상약학회지
• /
• 제30권2호
• /
• pp.81-86
• /
• 2020

Background: The number of patients with dementia continues to increase as the age of aging continues to grow. Psychiatric symptoms caused by senile dementia are controlled using antipsychotics. However, these antipsychotics can lead to Parkinson's disease, and abuse of dopamine derivatives such as levodopa among Parkinsonian drugs can lead to psychosis. Therefore, we evaluated the patterns of prescribed antipsychotics and antiparkinsonian drugs in patients with senile dementia. Methods: We used data from the sample of elderly patients from the Health Insurance Review and Assessment Service (HIRA-APS-2016). We analyzed the patterns of prescribing antipsychotics and antiparkinsonian drugs including prescribed daily dosage, period of prescription, and number of patients with both antipsychotics and antiparkinsonian drugs for senile dementia. Results: Among the 159,391 patients with dementia included in this analysis, 4,963 patients (3.1%) and 16,499 patients (10.4%) were prescribed typical and atypical antipsychotic drugs, respectively. The most frequently prescribed typical antipsychotic was haloperidol (4,351 patients with dementia), whereas the atypical agent was quetiapine (12,719 patients). The most frequently prescribed antiparkinsonian drugs were in the order of levodopa/carbidopa, benztropine, and ropinirole. In addition, 1,103 and 3,508 patients prescribed typical and atypical antipsychotics, respectively, were co-prescribed antiparkinsonian drugs. Conclusions: Atypical antipsychotics were the preferred prescription in patients with senile dementia. The prescription dose was relatively low; however, the average treatment duration was mostly long-term. Selection of antipsychotics and/or antiparkinsonian drugs should be made carefully in senile dementia and the causal relationship of adverse drug reactions needs further study.

• 대한한방내과학회지
• /
• 제37권2호
• /
• pp.337-344
• /
• 2016

Objective: This study reports on the efficacy of using traditional Korean medical treatments (herbal medicine, Shinbaro pharmacopuncture, and acupuncture) for atypical facial pain.Method: The patient was treated with herbal medicines (Chungsanggyuntong-tang and Yanghyeolgeopung-tang), acupuncture, and Shinbaro pharmacopuncture. The study was measured via the numerical rating scale (NRS) and the EuroQol five dimensions questionnaire (EQ-5D) to assess the treatments’ effectiveness.Results: After the treatments, the patient’s pain was controlled and the NRS score was decreased. The EQ-5D score also showed improvement.Conclusion: This case shows that traditional Korean medical treatments could be effective in easing the clinical symptoms of atypical facial pain.